These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8890678)

  • 41. Pentagastrin has panic-inducing properties in obsessive compulsive disorder.
    de Leeuw AS; Den Boer JA; Slaap BR; Westenberg HG
    Psychopharmacology (Berl); 1996 Aug; 126(4):339-44. PubMed ID: 8878350
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Guidelines on psychotropic drugs for the EC. Clinical investigation of medicinal products in the treatment of generalized anxiety disorder, panic disorder and obsessive-compulsive disorder.
    Eur Neuropsychopharmacol; 1995 Jun; 5(2):151-5. PubMed ID: 7549458
    [No Abstract]   [Full Text] [Related]  

  • 43. Adjunctive buspirone in benzodiazepine treatment of four patients with panic disorder.
    Gastfriend DR; Rosenbaum JF
    Am J Psychiatry; 1989 Jul; 146(7):914-6. PubMed ID: 2568095
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oculomotor performance in obsessive-compulsive disorder.
    Tien AY; Pearlson GD; Machlin SR; Bylsma FW; Hoehn-Saric R
    Am J Psychiatry; 1992 May; 149(5):641-6. PubMed ID: 1575255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clonazepam in the treatment of obsessive compulsive disorder associated with panic disorder in one patient.
    Bodkin JA; White K
    J Clin Psychiatry; 1989 Jul; 50(7):265-6. PubMed ID: 2738031
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Body image in social anxiety disorder, obsessive-compulsive disorder, and panic disorder.
    Aderka IM; Gutner CA; Lazarov A; Hermesh H; Hofmann SG; Marom S
    Body Image; 2014 Jan; 11(1):51-6. PubMed ID: 24095651
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Obsessive-compulsive symptoms associated with panic disorder. Predictive factor of a good therapeutic response to fluvoxamine].
    Servant D; Bailly D; Le Seac'h H; Parquet PJ
    Encephale; 1990; 16 Spec No():359-62. PubMed ID: 2120029
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of co-morbid generalized anxiety disorder, panic disorder and personality disorders on the outcome of cognitive behavioural treatment of obsessive-compulsive disorder.
    Hansen B; Vogel PA; Stiles TC; Götestam KG
    Cogn Behav Ther; 2007; 36(3):145-55. PubMed ID: 17943480
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of tandospirone, a 5-HT1A receptor-related anxiolytic, on daytime sleepiness and psychomotor functions: a comparative double-blind study with diazepam.
    Suzuki M; Uchiumi M; Murasaki M
    Yakubutsu Seishin Kodo; 1993 Aug; 13(4):213-24. PubMed ID: 7901952
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alexithymia in DSM-IV disorder: comparative evaluation of somatoform disorder, panic disorder, obsessive-compulsive disorder, and depression.
    Bankier B; Aigner M; Bach M
    Psychosomatics; 2001; 42(3):235-40. PubMed ID: 11351112
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quality of sleep in escitalopram-treated female patients with panic disorder.
    Todder D; Baune BT
    Hum Psychopharmacol; 2010 Mar; 25(2):167-73. PubMed ID: 20066671
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monoamine oxidase inhibitors in obsessive-compulsive disorder.
    Jenike MA; Surman OS; Cassem NH; Zusky P; Anderson WH
    J Clin Psychiatry; 1983 Apr; 44(4):131-2. PubMed ID: 6833198
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The emotional Stroop: a comparison of panic disorder patients, obsessive-compulsive patients, and normal controls, in two experiments.
    Kampman M; Keijsers GP; Verbraak MJ; Näring G; Hoogduin CA
    J Anxiety Disord; 2002; 16(4):425-41. PubMed ID: 12213037
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diazepam tolerance effects on vestibular function testing, Part I: Saccadic parameters during electronystagmography.
    Blau PA; Schwade N; Roland P
    Ann Otol Rhinol Laryngol; 2005 Aug; 114(8):621-8. PubMed ID: 16190095
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
    J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical comparison of Tourette's disorder and obsessive-compulsive disorder.
    Pitman RK; Green RC; Jenike MA; Mesulam MM
    Am J Psychiatry; 1987 Sep; 144(9):1166-71. PubMed ID: 3477103
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Panic and phobic disorders in patients with obsessive compulsive disorder.
    Austin LS; Lydiard RB; Fossey MD; Zealberg JJ; Laraia MT; Ballenger JC
    J Clin Psychiatry; 1990 Nov; 51(11):456-8. PubMed ID: 2228980
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changes in peripheral benzodiazepine receptors in patients with panic disorder and obsessive-compulsive disorder.
    Marazziti D; Rotondo A; Martini C; Giannaccini G; Lucacchini A; Pancioli-Guadagnucci ML; Diamond BI; Borison R; Cassano GB
    Neuropsychobiology; 1994; 29(1):8-11. PubMed ID: 8127425
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An explorative study on metacognition in obsessive-compulsive disorder and panic disorder.
    Cucchi M; Bottelli V; Cavadini D; Ricci L; Conca V; Ronchi P; Smeraldi E
    Compr Psychiatry; 2012 Jul; 53(5):546-53. PubMed ID: 22018834
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of the psychotropic profiles of tofisopam and diazepam.
    Bond A; Lader M
    Eur J Clin Pharmacol; 1982; 22(2):137-42. PubMed ID: 6124424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.